Intrathecal Administration of Autologous CD34 Positive Cells in Patients with Past Cerebral Infarction: A Safety Study

Table 1

Inclusion and exclusion criteria.

Inclusion criteria	Exclusion criteria
Age ≥18 years to ≤60 years	Systemic malignancy
Patient must comprehend the study protocol	Hematological system disorder (e.g., myeloproliferative disorder)
Patient must be compliant	Thrombocyte function disorders
Patient provided written informed consent	Metabolic syndrome with inadequate treatment parameters, for instance, excessive hypertension, hyperlipemia, and hyperglycemia
	Known deficit in hemostasis
	Serious coronary heart disease
	Sickle cell anemia
	Allergy against G-CSF
	Pregnancy
	Any other serious disease, for instance, severe psychiatric disorder (major depression, schizophrenic psychosis, and addiction), severe cardiac disorder with hemodynamic relevance and positive HIV serology
	Epilepsy; Hydrocephaly